Elizabeth Edwards and Breast Cancer: A Calm Look at What This Diagnosis Means

Six years, told in public

PBS NewsHour reported that Elizabeth Edwards was first diagnosed with breast cancer in 2004. In 2007 she announced that the cancer had returned. By December 2010 it had spread to her liver, and her doctors advised against further treatment.

Her family's statement said she had been advised by her doctors that further treatment of her cancer would be unproductive. She wrote on Facebook on December 6, 2010: "The days of our lives, for all of us, are numbered. We know that." She died the next day, at the age of 61.

Those are the disclosed facts. This article does not extend them, and it does not weigh any decision she or her doctors made. What follows explains what a breast cancer diagnosis involves, and what changes when the disease has spread.

What breast cancer is

NCI defines it simply. Breast cancer starts in the breast, in one or both, when breast cells grow without control and form a tumor that may spread elsewhere.

Most cancers begin in glandular tissue. Those starting in the milk ducts are called ductal cancers, and those starting in the milk-making lobules are lobular cancers. Most are ductal.

Two terms separate early from established disease. Carcinoma in situ means abnormal cells are still confined inside a duct or lobule. Invasive cancer has grown into surrounding breast tissue and can reach lymph nodes or distant organs. NCI notes that most breast cancers are invasive.

The American Cancer Society, whose projection SEER prints, expects about 321,910 new cases of female breast cancer in the United States in 2026, roughly 15.2 percent of all new cancer diagnoses, with about 42,140 deaths. The median age at diagnosis is 64.

What "spread" means

Stage IV, also called metastatic breast cancer, means the disease has traveled beyond the breast, the chest wall, and nearby lymph nodes. NCI describes the common destinations as bone, brain, liver, and lung.

The symptoms follow the site. NCI lists back pain, bone pain or fractures, shortness of breath, a constant dry cough, abdominal pain, swelling, jaundice, severe headaches, seizures, and vision changes among the signs of advanced or metastatic disease.

NCI is direct about the goal of treatment at this point. "Treatment of metastatic breast cancer focuses on slowing the spread of the cancer and controlling the symptoms." The choice of treatments depends partly on how the cancer responded to earlier therapy, and, in NCI's own words, on what the patient wants from treatment.

That last clause is not filler. At stage IV the decision is a trade between how a treatment may slow the disease and what it costs a person in side effects and time.

Recurrence is not the same as a new cancer

Two different things get called "the cancer came back."

Locoregional recurrence means the cancer has returned in the breast, the chest wall, or nearby lymph nodes. It is treated with the local and systemic tools used for earlier-stage disease.

Distant recurrence means it has reappeared in another organ. That is stage IV, and it is managed as metastatic disease from that point on, regardless of what stage the original tumor was.

What guides treatment

Three laboratory results matter more than almost anything else, and they are read from the tumor tissue itself.

The tumor is tested for estrogen receptors and progesterone receptors, and for levels of a protein called HER2. Hormone receptor positive cancers can be treated with hormone therapy that blocks or lowers estrogen. HER2-positive cancers can be treated with drugs aimed specifically at that protein. Triple-negative cancers, which have none of the three, are treated with chemotherapy and in some cases immunotherapy.

Stage is assigned twice. Clinical prognostic stage comes first, from history, examination, imaging, and biopsy. Pathological prognostic stage is assigned after surgery, from what the laboratory finds in removed tissue and lymph nodes. Both combine TNM status, tumor grade, and biomarker results into a number from 0 to IV.

For stages I to III, NCI describes treatment beginning with surgery, often followed by more therapy. When a tumor is large, chemotherapy or targeted therapy may be given first to shrink it. Locally advanced disease often starts with chemotherapy, followed by surgery and radiation.

NCI also makes a point about palliative care that is widely misunderstood. It can be given at any stage of disease, it aims to improve quality of life by managing symptoms, and it can be provided alongside treatments intended to cure.

When to get checked

NCI stresses that early breast cancer often causes no symptoms, which is why screening exists. When changes appear, NCI lists a lump in or near the breast or under the arm, a thick or firm area, a change in size or shape, nipple discharge that is not breast milk, a nipple that has flattened or changed direction, scaly or swollen skin, redness or darkening, itching of the nipple or areola, general swelling with no lump, a rash, and skin dimpling or puckering.

Book an appointment for:

• A new lump or firm area still present after one menstrual cycle, or after two to three weeks if you no longer menstruate.
• Nipple discharge that is not breast milk, especially from one side or containing blood.
• A newly inverted nipple, or skin dimpling and puckering.
• Redness or swelling of one breast that antibiotics do not clear.
• Bone pain that wakes you at night, a new persistent cough, or yellowing of the skin in anyone with a history of breast cancer.

NCI notes that breast cancer does not usually cause pain, so absence of pain is not reassurance. Persistent breast pain still deserves a visit.

The US Preventive Services Task Force recommends screening mammography every two years for women aged 40 to 74, a grade B recommendation. For women 75 and older it finds the evidence insufficient, and it reaches the same conclusion on adding ultrasound or MRI for women with dense breasts.

What the numbers say, and do not

Five-year relative survival for female breast cancer is 91.9 percent across all stages for women diagnosed between 2016 and 2022. By stage it is 100 percent for localized disease, 87.5 percent for regional spread, and 33.8 percent when the cancer has reached distant organs.

Relative survival compares people with the cancer to people of the same age and sex without it, which is why the localized figure reaches 100 percent. About 64 percent of cases are localized at diagnosis, and 6 percent are distant.

Those figures average across hundreds of thousands of women with different tumor biology, ages, and treatments. They set context and nothing else. They describe no individual, they did not describe Elizabeth Edwards, and they cannot tell any reader what lies ahead.

Sources

• https://www.cancer.gov/types/breast/what-is-breast-cancer
• https://www.cancer.gov/types/breast/symptoms
• https://www.cancer.gov/types/breast/stages
• https://www.cancer.gov/types/breast/treatment/by-stage
• https://seer.cancer.gov/statfacts/html/breast.html
• https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
• https://www.npr.org/sections/itsallpolitics/2010/12/07/131885469/elizabeth-edwards-dies-from-cancer-at-61
• https://www.pbs.org/newshour/nation/elizabeth-edwards-dies-at-age-61